Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_240
Snippet: However, a recent systematic review identified that unbiased, adequately powered, long-term comparisons of insulin types are lacking. A one-year, prospective, randomized clinical trial was conducted to compare the glycemic control and remission rates associated with glargine (Lantus Ã’ , Sanofi) or human-recombinant PZI (PZIR; ProZinc Ã’ , Boehringer Ingelheim) therapy in diabetic cats......
Document: However, a recent systematic review identified that unbiased, adequately powered, long-term comparisons of insulin types are lacking. A one-year, prospective, randomized clinical trial was conducted to compare the glycemic control and remission rates associated with glargine (Lantus Ã’ , Sanofi) or human-recombinant PZI (PZIR; ProZinc Ã’ , Boehringer Ingelheim) therapy in diabetic cats.
Search related documents:
Co phrase search for related documents- clinical trial and human recombinant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- clinical trial and insulin type: 1, 2
- clinical trial and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and long term comparison: 1
- clinical trial and prospective randomized clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and randomized clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical trial and year prospective randomized clinical trial: 1
- glycemic control and human recombinant: 1, 2
- glycemic control and insulin type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- glycemic control and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- glycemic control and long term comparison: 1
- glycemic control and prospective randomized clinical trial: 1, 2, 3
- glycemic control and randomized clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9
- glycemic control and remission glycemic control: 1, 2, 3, 4, 5, 6
- glycemic control and remission glycemic control rate: 1
- human recombinant and insulin type: 1
- human recombinant and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- human recombinant and prospective randomized clinical trial: 1
- human recombinant and randomized clinical trial: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date